Browsing bySubjectImmune checkpoint blockade

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 8 of 8

Issue DateTitleAuthor(s)Type
2023All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy김광명Article
2024Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy김진성; 이용현; 김광명Article
2020Harnessing the bioresponsive adhesion of immuno-bioglue for enhanced local immune checkpoint blockade therapy주계일Article
2026High-dose treatment of cathepsin B-activatable doxorubicin prodrug nanoparticles that induce tumor-specific immunogenic cell death for immunotherapy of melanoma with minimal systemic toxicity김진성; 김광명Article
2022Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light김광명Article
2022Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity김광명Article
2024Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy김광명Article
2024Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma임선아Article

BROWSE